Top 10 Building Product Companies To Buy For 2015

On Tuesday,  (NASDAQ: AMZN  )  stock closed within 1% of its 52-week-high as the company announced Amazon Birthday Gift, “a new way for customers to surprise friends on their birthdays by joining together to send Gift Cards with birthday messages” on Facebook (NASDAQ: FB  ) .

Image source:

So how does it work?  

In short, anyone with a Facebook account can “start” a gift through Amazon for as little as $1 along with a custom birthday message. Then, other Facebook friends can add their own messages while incrementally increasing the gift card by $1, $5, $10, or $25, allowing the gift to grow until the recipient’s birthday.

Then, on the birthday, the “many individual birthday messages will appear on his or her Timeline along with links to claim the gift — surprising the recipient with much more than just the traditional birthday messages and letting the recipient get exactly what he or she wants from millions of items on Amazon.”

Top 10 Building Product Companies To Buy For 2015: Castle Brands Inc. (ROX)

Castle Brands Inc. develops and markets beverage alcohol products. The company provides rum, whiskey, liqueurs, vodka, tequila, and wine. It offers its products under various brands, including Gosling’s Rum, Gosling’s Dark ‘n Stormy, Jefferson’s, Jefferson’s Reserve and Jefferson’s Presidential Select, Jefferson’s Rye, Clontarf, Pallini, Boru, Knappogue Castle Whiskey, Tierras, Celtic Honey, Brady’s Irish Cream, Travis Hasse’s Original Pie, Gozio, A. de Fussigny, and CC. The company offers its products through a network of wholesale distributors and state-operated agencies in the United States, Ireland, Great Britain, Northern Ireland, Germany, Canada, South Africa, Bulgaria, France, Russia, Finland, Norway, Sweden, and China, as well as in continental Europe and Latin America. Castle Brands Inc. is based in New York, New York.

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another stock that’s rapidly moving within range of triggering a big breakout trade is Castle Brands (ROX), which develops and markets premium and super-premium brands in the beverage alcohol categories: rum, whiskey, liqueurs, vodka, tequila and fine wine. This stock has been on fire so far in 2013, with shares up huge by 234%.

    If you take a look at the chart for Castle Brands, you’ll notice that this stock has been uptrending very strong for the last three months, with shares soaring higher from its low of 30 cents per share to its recent high of 99 cents per share. During that uptrend, shares of ROX have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of ROX within range of triggering a big breakout trade.

    Market players should now look for long-biased trades in ROX if it manages to break out above some near-term overhead resistance levels at 93 cents per share to its 52-week high at 99 cents per share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 501,958 shares. If that breakout triggers soon, then ROX will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $1.50 to $2 a share.

    Traders can look to buy ROX off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at 80 cents to 77 cents per share, or around its 50-day at 70 cents per share. One can also buy ROX off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top 10 Building Product Companies To Buy For 2015: Elan Corporation PLC (ELN)

Elan Corporation, plc (Elan), incorporated in December 1969, is a neuroscience-based biotechnology company. The Company is focused on discovering and developing advanced therapies in neurodegenerative and autoimmune diseases. Elan’s business focuses on neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease; autoimmune diseases, including MS and Crohn’s disease and neo-epitope based targets for treatments across a range of therapeutic indications. Tysabri is a treatment for MS and Crohn’s disease that the Company markets and distributes with Biogen Idec. On September 16, 2011, Elan sold its EDT business to Alkermes, Inc. In November 2011, Elan launched a collaboration with the University of Cambridge, England, the Cambridge-Elan Centre for Research Innovation and Drug Discovery (Cambridge-Elan Centre). On December 21, 2012, the Company completed the demerger of Prothena Corporation plc. In April 2013, it closed the TYSABRI (natalizumab) Co llaboration Transaction with Biogen Idec.


Tysabri, which is an alpha-4 integrin inhibitor, is a therapy for MS, a neurological disorder involving central nervous system dysfunction among adults. Tysabri is approved in more than 65 countries. Tysabri is approved in the United States as a monotherapy for relapsing forms of MS, for patients who have had an inadequate response to, or are unable to tolerate, an alternative MS therapy. In the European Union, it is approved for relapsing-remitting MS (RRMS) in adult patients who have failed to respond to beta interferon or have rapidly evolving, severe RRMS. As of December 31, 2011, there were approximately 64,400 patients on Tysabri therapy worldwide.

In June 2011, the European Commission (EC) approved the inclusion of the anti-JCV antibody status as an additional factor in stratifying patients at risk for developing PML in the Summary of Product Characteristics’ (SmPC) for Tysabri in the European Union. The Company has developed a two-step ! enzyme-linked immunosorbent assay (ELISA), STRATIFY JCV, with Biogen Idec. The assay detects anti-JCV antibodies in the blood of patients, and is commercially available in Europe. In January 2012, the FDA cleared the assay for commercial use in the United States. As of December 31, 2011, over 80,000 tests had been administered using the assay. Tysabri is marketed and distributed by Elan and Biogen Idec. The Company’s research group, Neotope, is focused on creating monoclonal antibodies based on neo-epitope targets for the treatment of a range of therapeutic indications.

Beta Amyloid Immunotherapies (AIP)

Beta amyloid immunotherapy includes the treatment of Alzheimer’s disease by inducing or enhancing the body’s immune response in order to clear toxic species of beta amyloid from the brain. The AIP includes bapineuzumab (intravenous and subcutaneous delivery) and ACC-001, as well as other compounds. Bapineuzumab is an experimental humanized mon oclonal antibody delivered intravenously that is being studied as a treatment for mild to moderate Alzheimer’s disease. It is designed to provide antibodies to beta amyloid directly to the patient (passive immunotherapy).

ELND005, an Aß Aggregation Inhibitor

The small molecule ELND005 (Scyllo-inositol) is a beta amyloid anti-aggregation agent. Preclinical data suggest that ELND005 may act through the mechanism of preventing and reversing the fibrilisation of beta amyloid (the aggregation of beta amyloid into clumps of insoluble oligomers). ELND005 may have additional applications in psychiatric indications, such as bipolar disorder. In November 2011, the Company entered into a manufacturing agreement for the supply of the active pharmaceutical ingredient for ELND005 with Lonza Group AG.

Neotope Biosciences Limited

Neotope Biosciences Limited (Neotope) is the Company’s wholly owned subsidiary that focuses on the discove ry and development of antibodies to neo-epitope related targ! ets for t! he treatment of a range of indications. It includes amyloidosis, diabetes, cancer and macular degeneration. Neotope’s portfolio of targets includes alpha-synuclein for the potential treatment of synucleinopathies, such as Lewy body dementia and Parkinson’s disease, tau for Alzheimer’s disease and other tauopathies. It also has a program for type 2-diabetes.

Onclave Therapeutics Limited

Elan’s wholly owned subsidiary Onclave Therapeutics Limited (Onclave) was formed to develop assets originating from Elan that have application in oncology related diseases. Onclave’s program, NEOD001, which originated from Neotope, is being investigated for the treatment of AL amyloidosis, which is a fatal disease involving abnormal accumulation of amyloid in organs and tissue. During the year ended December 31, 2011, Onclave filed for orphan drug designation of NEOD001. Onclave’s pipeline includes additional compounds with relevance in diverse cancer indi cations.

The Company competes with Biogen Idec, Bayer Schering Pharma AG, Bayer Schering Pharma, Merck Serono, Pfizer, Teva Neurosciences, Inc., Sanofi-Aventis and Novartis AG.

Advisors’ Opinion:


    Add Amgen Inc.’s (Nasdaq: AMGN) August $10.4 billion offer for Onyx Pharmaceuticals Inc. (Nasdaq: ONXX), Perrigo Co.’s (NYSE: PRGO) July purchase of Elan Corp. (NYSE ADR: ELN) for $8.6 billion, and the Shire deal, and the year-to-date deal value for pharma/biotech M&A hits more than $50 billion.

  • [By Brian Orelli]

    Royalty Pharma announced Monday that it’s willing increase the $11-per-share offer it made for Elan (NYSE: ELN  ) back in February, depending on the result of Elan’s buyback.

  • [By Tim Brugger]

    After confirming an unsolicited takeover bid from privately held investment firm Royalty Pharma in late February, Ireland-based Elan (NYSE: ELN  ) announced today that its board has unanimously rejected the offer.

  • [By Brian Orelli]

    Most recently Elan (NYSE: ELN  ) spun out its drug discovery business into Prothena. Without the burden of a drug discovery unit, the parent company is now being pursued by Royalty Pharma, although Elan isn’t keen on its current offer.

Top 10 Building Product Companies To Buy For 2015: Newpark Resources Inc (NR)

Newpark Resources, Inc., incorporated on June 3, 1988, is a diversified oil and gas supplier providing products and services primarily to the oil and gases exploration (E&P) industry. The Company operates in three segments: fluids systems and engineering, mats and integrated services, and environmental services. The Company’s Fluids Systems and Engineering segment provides customized drilling fluids solutions to E&P customers globally, operating through four geographic regions: North America, Europe, the Middle East and Africa (EMEA), Latin America, and Asia Pacific. The Company’s Mats and Integrated Services segment provides composite mat rentals, well site construction and related site services to oil and gas customers at well, production, transportation and refinery locations in the United States. The Company’s Environmental Services segment processes and disposes of waste generated by E&P and industrial activity, primarily along the United States Gulf Coast. On Decembe r 31, 2012, it acquired operations of Alliance Drilling Fluids, LLC

Fluids Systems and Engineering

The Company’s Fluids Systems and Engineering business offers customized solutions, including technical drilling projects involving complex subsurface conditions, such as horizontal, directional, geologically deep or deep water drilling. These projects require increased monitoring and critical engineering support of the fluids system during the drilling process. The Company provides drilling fluids products and technical services to markets in North America, EMEA, Latin America, and the Asia Pacific region. The Company also provides completion services and equipment rental to customers in Oklahoma and Texas. The Company has industrial mineral grinding operations for barite. The Company grinds barite and other industrial minerals at facilities in Houston and Corpus Christi, Texas, New Iberia, Louisiana and Dyersburg, Tennessee. The Company uses the resul ting products in its drilling fluids business, and also sell! s them to third party users, including other drilling fluids companies. The Company also sells a variety of other minerals, principally to third party industrial (non oil and gas) markets, from its main plant in Houston, Texas and from the plant in Dyersburg, Tennessee.

Mats and Integrated Services

The Company provides mat rentals, location construction and related well sites services to E&P customers in the Northeast United States, onshore United States Gulf Coast, and Rocky Mountain regions, and mat rentals to the petrochemical industry in the United States and the utility industry in the United Kingdom. These mats provide environmental protection and ensure all-weather access to sites with unstable soil conditions. The Company manufactures its DuraBase Advanced Composite Mats for sales, as well as for uses in its domestic and international rental operations. The Company’s marketing efforts for this product remain focused in principal oil and gas industry markets which include the Asia Pacific, Latin America, EMEA, as well as markets outside the E&P sector in the United States and Europe.

Environmental Services

The Company processes and disposes of waste generated by its oil and gas customers. Primary revenue sources include onshore and offshore Gulf of Mexico drilling waste management, as well as reclamation services. Additionally, the Company provides disposal services in the West Texas market. The Company operates six receiving and transfers facilities located along the United States Gulf Coast. E&P waste is collected at the transfer facilities from drilling and production operations located offshore, onshore and within inland waters. Waste is accumulated at the transfer facilities and moved by barge through the Gulf Intracoastal Waterway to the Company’s processing and transfer facility at Port Arthur, Texas, and, if not recycled, is trucked to injection disposal facilities. Any remainin g material is injected, after further processing, into envir! onmentall! y secure geologic formations. Under permits from Texas state regulatory agencies, the Company operates waste disposal facilities in Jefferson County, Texas (Fannett and Big Hill). The Fannett site is the Company’s primary facility for disposing of E&P waste. Utilizing this same technology, the Company also receives and disposes of non-hazardous industrial waste at the Big Hill facility, principally from generators in the United States Gulf Coast market, including refiners, manufacturers, service companies and industrial municipalities that produce waste. These non-hazardous waste streams are injected into a separate well utilizing the same low-pressure injection technology. The Company also disposes of non-hazardous industrial waste.

The Company competes with Schlumberger, Halliburton and Baker Hughes.

Advisors’ Opinion:

  • [By Travis Hoium]

    What: Shares of energy service provider Newpark Resources (NYSE: NR  ) jumped 17% today after the company released earnings.

    So what: Revenue was up 7.7%, to $283 million in the first quarter, and net income jumped 11.1%, to $17.4 million, or $0.18 per share. Analysts only expected $278 million in revenue, and earnings of $0.17 per share, and the slight beat was enough to send shares higher. It didn’t hurt that the report was accompanied by a $50 million share repurchase plan, which indicates that management is bullish on the company’s long-term future. 

Top 10 Building Product Companies To Buy For 2015: Pixelworks Inc.(PXLW)

Pixelworks, Inc., together with its subsidiaries, engages in the design, development, and marketing of video and pixel processing semiconductors and software for digital video applications. Its products include ImageProcessor integrated circuits (ICs), which comprise embedded microprocessors, digital signal processing technology, and software that control the operations and signal processing within high-end display systems, such as projectors and high-resolution flat panels; Video Co-Processor ICs that work in conjunction with an image processor to post-process video signals to enhance the performance or feature set of the overall video solution; and Networked Display ICs, which allow the same video stream to be networked across multiple displays. The company serves the manufacturers of digital display and projection devices, such as liquid crystal display (LCD) large-screen televisions and 3LCD, and digital light processing digital front projectors, as well as the flat pa nel display market, including digital signage. Pixelworks, Inc. sells its products through its direct sales force, distributors, and manufacturers? representatives in Japan, Taiwan, China, Korea, the United States, Europe, and southeast Asia. The company was founded in 1997 and is based in San Jose, California.

Advisors’ Opinion:

  • [By Roberto Pedone]

    Pixelworks (PXLW) designs, develops, and markets video and pixel processing semiconductors, software, and custom ASIC solutions for digital video applications. This stock closed up 8.5% to $6.60 in Tuesday’s trading session.

    Tuesday’s Range: $6.11-$6.63
    52-Week Range: $3.63-$9.83
    Tuesday’s Volume: 1.82 million
    Three-Month Average Volume: 1.16 million

    From a technical perspective, PXLW ripped sharply higher here right above some near-term support at $6 with above-average volume. This strong rip to the upside on Tuesday is quickly pushing shares of PXLW within range of triggering a near-term breakout trade. That trade will hit if PXLW manages to take out Tuesday’s intraday high of $6.63 and then once it clears its recent gap-down-day high right below $7 with high volume.

    Traders should now look for long-biased trades in PXLW as long as it’s trending above Tuesday’s intraday low of $6.11 or above $6 and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.16 million shares. If that breakout hits soon, then PXLW will set up to re-fill some of its previous gap-down-day zone from July that started just above $8.

  • [By Paul Ausick]

    Another heavily traded Nasdaq stock today is Pixelworks Inc. (NASDAQ: PXLW). The maker of of video processing chips said that Apple Inc. (NASDAQ: AAPL) contributed more than 10% to the company’s revenues last year. Analysts expect more upside for the company this year and next as a result. Pixelworks’ shares are looking to close up 84.37% at $8.88 in a 52-week range of $2.11 to $9.05 (a new 52-week high today). Share volume was approaching 15-times more than the daily average of around 500,000 shares traded.

Top 10 Building Product Companies To Buy For 2015: Clearbridge Energy MLP Fund Inc (CEM)

ClearBridge Energy MLP Fund Inc. (the Fund) is a non-diversified, closed-end management investment company. The Fund’s investment objective is to provide a high level of total return with focus on cash distributions. The Fund seeks to achieve its objective by investing primarily in master limited partnerships (MLPs) in the energy sector. Under normal market conditions, the Fund will invest at least 80% of its managed assets in MLPs in the energy sector (the 80% policy). Entities in the energy sector are engaged in the business of exploring, developing, producing, gathering, transporting, processing, storing, refining, distributing, mining or marketing of natural gas, natural gas liquids (including propane), crude oil, refined petroleum products or coal. Legg Mason Partners Fund Advisor, LLC is the Fund’s investment manager and ClearBridge Advisors, LLC is the Fund’s subadviser. Advisors’ Opinion:

  • [By Robert Abbott]

    For OTEX, this includes five distinct groups of services:

    Enterprise Content Management (ECM), which includes records management, archiving, and email services Business Process Management (BPM), including software for analyzing and optimizing business processes Customer Experience Management (CEM), includes software that integrates internal and external content to enhance the ‘customer experience’ Information Exchange (iX), “…a set of offerings that facilitate efficient, secure, and compliant exchange of information inside and outside the enterprise.” Discovery, which includes the indexing, navigation, and retrieval of information in databases (for a fuller description of these segments, see the 10-K Report for 2014).

    As of June 30, 2014 it employed about 8,000, including 2,000 in cloud services, 1,900 in product development and 1,400 in sales and marketing.

Top 10 Building Product Companies To Buy For 2015: Banro Corp (BAA)

Banro Corporation (Banro) is a Canada-based gold exploration company. The Company holds, through four wholly owned subsidiaries, a 100% interest in four gold properties, which are known as Twangiza, Namoya, Lugushwa and Kamituga. These properties are covered by a total of 13 exploitation permits and are found along the 210 kilometer-long Twangiza-Namoya gold belt in the South Kivu and Maniema Provinces of eastern Democratic Republic of the Congo (DRC). The Company also holds 14 exploration permits covering an aggregate of 2,638 square kilometers. Its 10 of the permits are located in the vicinity of the Company’s Twangiza property and four are located in the vicinity of the Company’s Namoya property. During the year ended December 31, 2011, the Company was engaged in the construction of the Company’s Twangiza Phase I oxide mine, and continued its exploration activities at its Twangiza, Namoya and Lugushwa properties. Advisors’ Opinion:

  • [By Anthony Mirhaydari]

    I’ve added shares of BVN to my Edge Letter Sample Portfolio.

    Breakout Gold Stocks to Buy: Banro (BAA)

    Click to Enlarge Banro (BAA) is a gold mining outfit with operations in the Democratic Republic of the Congo. The company recently announced a 15% increase in gold production in the fourth quarter thanks to expansion and efficiency gains at its Twangiza facility.

  • [By Bryan Murphy]

    Looking for a couple of long (bullish) trading ideas on a day when the market is dragging pretty much everything lower? There are two names that fit the bill…CombiMatrix Corp. (NASDAQ:CBMX) and Banro Corporation (NYSEMKT:BAA). CBMX is an “almost” small cap stock that deserves a place on your watchlist while we wait for it to do one more thing. Meanwhile, BAA is something worth going ahead and taking a swing on now, not despite the market’s tumble, but because of it.

  • [By Bryan Murphy]

    With the weekend just around the corner – and with folks looking to close the books on what’s been a miserable week – most traders have already closed shop and gone home. Big mistake. Some of the best trades I’ve ever found were uncovered when nobody else cared, or was interested. Enter Banro Corporation (NYSEMKT:BAA)… a name I stumbled cross today when few other were even looking. I think BAA could be an explosive bullish mover over the course of the next few weeks. Though I don’t want to get married to it, I sure wouldn’t mind dating it for a while.

Top 10 Building Product Companies To Buy For 2015: The Blackstone Group L.P.(BX)

The Blackstone Group, L.P., together with its subsidiaries, provides alternative asset management and financial advisory services worldwide. The company operates in five segments: Private Equity, Real Estate, Hedge Fund Solutions, Credit Businesses, and Financial Advisory. The Private Equity segment involves in private equity investing through five general private equity funds and one specialized fund focusing on communications-related investments. This segment engages in various transactions comprising leveraged buyout acquisitions of seasoned companies, transactions involving growth equity or start-up businesses in established industries, minority investments, corporate partnerships, distressed debt, structured securities, and industry consolidations. The Real Estate segment manages general opportunistic real estate funds and internationally focused opportunistic real estate funds. This segment also has debt investment funds targeting non-controlling real estate debt-rel ated investment opportunities in the public and private markets, primarily in the United States and Europe. The Hedge Fund Solutions segment manages funds of hedge funds, and Indian-focused and Asian-focused closed-end mutual funds. The Credit Businesses segment manages credit-oriented funds, CLOs, credit-focused separately managed accounts, and publicly registered debt-focused investment companies. The Financial Advisory segment offers financial and strategic advisory, including corporate finance, and mergers and acquisitions advice; restructuring and reorganization advisory; and fund placement services for alternative investment funds. Blackstone Group Management L.L.C. operates as the general partner of the company. The Blackstone Group, L.P. was founded in 1985 and is headquartered in New York, New York.

Advisors’ Opinion:

  • [By Jayson Derrick]

    Bloomberg first reported that Blackstone (NYSE: BX) plans to spin off its financial advisory division. The company confirmed that it will spin off the division to a new publicly-traded firm. Blackstone holders will own around 65 percent of the new company. Shares lost 0.57 percent, closing at $29.60.

  • [By Matt Egan]

    Other financial firms set to reveal results this week include Blackstone (BX), Citigroup (C) and Morgan Stanley (MS).

      Running of the bull markets

    Tech titans to the rescue: Expect tech stocks to be the rock stars on earnings this week.

Top 10 Building Product Companies To Buy For 2015: Acura Pharmaceuticals Inc.(ACUR)

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and manufacture of pharmaceutical product candidates utilizing its proprietary Aversion and Impede technologies. Its Aversion Technology is a proprietary platform technology providing abuse deterrent features and benefits to orally administered pharmaceutical drug products containing abusable active ingredients, such as tranquillizers, stimulants, sedatives, and decongestants. The company offers OXECTA Tablets CII, which are oral formulations of oxycodone HCl for the management of acute and chronic moderate to severe pain; and Impede PSE, a pseudoephedrine hydrochloride tablet product candidate. It is also developing opioid analgesic product candidates, which would be used to relieve pain while discouraging common methods of opioid product misuse and abuse, including intravenous injection of dissolved tablets or capsules; nasal snorting of crushed tablets or capsules; and intentional swallowing of excess quantities of tablets or capsules. In addition, the company investigates and develops mechanisms to incorporate abuse deterrent features into abused and misused pharmaceutical products using its Impede Technology. Acura Pharmaceuticals, Inc. has a license, development, and commercialization agreement with King Pharmaceuticals Research and Development, Inc. to develop and commercialize certain opioid analgesic products utilizing the company?s proprietary Aversion Technology in the United States, Canada, and Mexico. The company was founded in 1935 and is based in Palatine, Illinois.

Advisors’ Opinion:

  • [By Rick Munarriz]

    Acura Pharmaceuticas (NASDAQ: ACUR  ) checks in on Thursday. Drugmakers use Acura’s Aversion and Impede technologies to create abuse-deterrent treatments. In short, if an abuser tries to extract the active ingredient of a drug to heighten addictive experiences, Acura’s technologies kick in to make the whole dose unusable.

  • [By Sean Williams]

    ALKS-7106 for the treatment of pain has big potential as it encompasses a broad audience, but it’ll need to overcome the common stigma of pain drugs with regard to easy abuse potential. According to the press release, Alkermes will be introducing newer technology that will make its opioid-based drug more resistant to abuse. It should be curious to see how well this performs as there aren’t many successful abuse-resistant drugs, or companies developing those drugs for that matter. Acura Pharmaceuticals (NASDAQ: ACUR  ) , for instance, successfully brought moderate-to-severe painkiller Oxecta to market in 2011 (which it subsequently licensed to Pfizer) and a bioequivalent version of decongestant pseudoephedrine to market last year, but sales of neither drug has exactly taken off. Like with its MMF prodrug, Alkermes anticipates a mid-2014 clinical trial launch date.

  • [By John Udovich]

    On Tuesday, small cap specialty pharmaceutical company Acura Pharmaceuticals, Inc (NASDAQ: ACUR) surged 27.52% to $1.90 on no apparent news beyond a speculative Seeking Alpha article that talked about certain catalysts  – meaning its worth taking a closer look at the company to see what’s going on and whether shares could move higher. 

Top 10 Building Product Companies To Buy For 2015: Altria Group(MO)

Altria Group, Inc., through its subsidiaries, engages in the manufacture and sale of cigarettes, smokeless products, and wine in the United States and internationally. It offers cigarettes under the Marlboro, Virginia Slims, Parliament, Benson & Hedges, Basic, and L&M brands; smokeless tobacco products under the Copenhagen, Skoal, Red Seal, Husky brands, and Marlboro snus brands; and machine-made large cigars and pipe tobacco. The company also produces and sells blended table wines under the Chateau Ste Michelle and Columbia Crest names; and distributes Antinori and Villa Maria Estate wines and Champagne Nicolas Feuillatte in the United States. In addition, it maintains a portfolio of leveraged and direct finance leases in rail and surface transport, aircraft, electric power, real estate, and manufacturing. The company sells its tobacco products to wholesalers, including distributors; large retail organizations, such as chain stores; and the armed services. Altria Group, I nc. markets its wine products to restaurants, wholesale clubs, supermarkets, wine shops, and mass merchandisers. The company was founded in 1919 and is headquartered in Richmond, Virginia.

Advisors’ Opinion:

  • [By ovenerio]

    In this article, let´s see one of the most important financial ratios applying to stockholders, the best measure of performance for a firm’s management: the Return on Equity (ROE), and we are going to analyze it in the case of Altria Group Inc. (MO), a $93.34 billion market cap company, which is the largest U.S. cigarette producer with roughly 50% share.

  • [By Anders Bylund]

    Let’s take a look at three classic dividend growers: Procter & Gamble (NYSE: PG  ) , Altria Group (NYSE: MO  ) , and McDonald’s (NYSE: MCD  ) . These classic cash machines have increased their payouts without fail for at least 37 consecutive years, creating heaps of investor wealth in the process.

  • [By Dan Caplinger]

    When it comes to consistently treating dividend investors well, Altria Group (NYSE: MO  ) scores in the upper echelon of dividend stocks in the market. With a solid dividend track record that reaches back for decades, Altria has managed to overcome numerous challenges that threatened its very existence and rewarded those who stuck with the tobacco giant. Yet looking forward, as you assess whether Altria would make a good addition to your dividend portfolio, there are a couple things you should keep in mind to help you make the best decision. Let’s look more closely at two things every dividend investor should know about Altria Group.

Top 10 Building Product Companies To Buy For 2015: M.D.C. Holdings Inc. (MDC)

M.D.C. Holdings, Inc., through its subsidiaries, engages in homebuilding and financial services businesses in the United States. Its homebuilding business activities include the purchase of finished lots or development of lots for the construction and sale of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name. The company’s financial services business activities comprise the origination of mortgage loans primarily for homebuyers; provision of third-party insurance products to homebuyers; and title agency services to homebuyers in Colorado, Florida, Maryland, Nevada, and Virginia. It also provides insurance coverage on homes sold and for work performed in completed subdivisions; and re-insures the claims. M.D.C. Holdings, Inc. was founded in 1972 and is based in Denver, Colorado.

Advisors’ Opinion:

  • [By Lisa Levin]

    MDC Holdings (NYSE: MDC) shares fell 1.16% to touch a new 52-week low of $25.60. MDC Holdings’ PEG ratio is 3.14.

    PDF Solutions (NASDAQ: PDFS) shares reached a new 52-week low of $12.91. PDF Solutions updated the status of certain contracts and announced the effect of the change in status on previously deferred costs and expected revenues.

  • [By Charley Blaine]

    Among the losers: AIG, down 6.9 percent; gold-miner Newmont Mining (NYSE: NEM), down 4.7 percent; and homebuilder M.D.C. Holdings (NYSE: MDC), down 1.37 percent.

  • [By Rich Smith]

    Upping MDC Holdings to buy
    Before moving on to the bad news, let’s start with some good. Investment banker KeyBanc Capital Markets thinks that in view of the broad strength in housing stocks lately, it’s time to revisit the sector, take some winnings off the table, and move a bit of that money into stocks with perhaps a bit more potential to keep growing. It’s choice today: MDC Holdings (NYSE: MDC  ) .

  • [By The Oxen Group]

    MDC Holdings (MDC) through its subsidiary Richmond American Homes builds new single family homes in various regions of the country and provides mortgage services as well. We initiate a BUY recommendation as we believe company shares have the potential to appreciate by 50% in the next 12 months. MDC is entering the upscale housing market that, if profitable, could potentially lead the way to further development in this direction. The company could also see a revenue boost and better market share due to implementations of new standard energy features that separates itself from competition.